Advances in Gerontology Gerontology

Subcellular Therapy: Targeting Mitochondrial DNA Mutations. Clinical Case Report

A. N. Orekhov, V. I. Summerhill, V. A. Orekhova, M. Y. Vyssokikh, M. V. Marey, V. V. Sinyov, I. A. Sobenin
Springer Nature · 2026-06-01 · DOI 10.1134/s2079057026600084

Abstract

Abstract Mitochondrial dysfunction is a recognized contributor to pathogenesis of atherosclerosis. Several studies suggested that 5-aminolevulinic acid (5-ALA) may specifically target dysfunctional mitochondria. The objective of this study was to test the hypothesis that 5-ALA could promote the selective removal of dysfunctional mitochondria within cells, thereby restoring mitochondrial function in cybrid cell lines harboring mitochondrial mutations associated with atherosclerosis. Cybrid lines were created by the fusion of (rho0) THP-1 linear cells (a human monocytic leukemia cell line without mitochondria) and platelets carrying mitochondria with pro-atherogenic mutations obtained from the blood of atherosclerotic patients. Cybrid cell lines were studied using a confocal microscope. The fluorescence was assessed by flow cytometry using tetramethylrhodamine (TMRM), a cell-permeating dye, that accumulates in active mitochondria with intact membrane potential. A pilot clinical trial study involving a human volunteer was conducted to verify the impact of 5-ALA on mitochondria after its long-term administration. It was found that treatment of cultured cells with 5-ALA leads to depolarization and a decrease in the number of mitochondria, presumably due to stimulation of mitophagy. The effect was observed in cybrid lines, carrying mitochondria with atherosclerosis-associated mutations. The in vitro experiments were verified in vivo. Long-term 5-ALA treatment resulted in the elimination of mitochondria with certain mutations, which was observed in circulating monocytes in a volunteer. A 7-month administration of 5-ALA to a human volunteer resulted in changes in the degree of heteroplasmy of several mitochondrial mutations associated with atherosclerosis. The findings of this study suggest that the accumulation of substances within mitochondria, caused by metabolic disturbances, may drive the elimination of impaired mitochondria through excessive intramitochondrial accumulation of these compounds.

Read at publisher →